Date:30/06/2007 URL: http://www.thehindu.com/2007/06/30/stories/2007063050821600.htm

Business - Briefly

Eli Lilly sells antibiotic brand to Pharmalink

CHENNAI: Eli Lilly and Company [India] Pvt. Ltd. on Friday announced the divestiture of its premier antibiotic brand, Distaclor (Cefaclor) to Pharmalink, a subsidiary of the Quintiles International, effective July 1, for an undisclosed sum. Pharmalink is a global player in contract research and sales, according to a release.